ANDRULIS PHARMACEUTICALS CORPORATION
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Oct 31, 2000 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 448 Total Citation Count
- Dec 26, 1985 Earliest Filing
- 2 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6140346 Treatment of cancer with thalidomide alone or in combination with other anti-cancer agentsMay 04, 98Oct 31, 00[A61K]
5731325 Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agentsJun 06, 95Mar 24, 98[A61K]
5654312 Treatment of inflammatory and/or autoimmune dermatoses with thalidomide alone or in combination with other agentsJun 07, 95Aug 05, 97[A61K]
5643915 Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapiesJun 06, 95Jul 01, 97[A61K, A01N]
Expired/Abandoned/Withdrawn Patents
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.